PRIVATE EQUITY FIRMS
RxMarketSCIENCE works with Private Equity and Venture Capital firms to bring industry expertise throughout the M&A deal cycle and beyond . Our expertise is available for quick opinions, targeted research OR for full deal cycle and post acquisition growth engagements.
RxMarketSCIENCE serves some of the most ambitious firms in the US and aboard. Our clients come to us seeking our advice, opinions, research and analysis expertise. RxMarketSCIENCE is a practice oriented team and understands the importance of practical needs of our clients. RxMarketSCIENCE is an indispensable part of our client's decision making process. Below are some of the major types of clients we serve.
MANAGEMENT CONSULTING FIRMS
RxMarketSCIENCE Enhances general management consulting firm's capabilities and augment their team with our industry expertise to shorten their team's learning cycle, assist market research efforts with deeper knowledge and enhances firm's credibility in front of clients who regard industry experience and targeted research capability by a firm dedicated to the end-to-end prescription drug industry.
RxMarketSCIENCE brings cross-segment knowledge and fresh outside perspectives into corporate strategy departments when strategic decisions and innovations cross-over segment boundaries and requires entrepreneurial agility, market experimentations and practice oriented research skills.
RxMarketSCIENCE helps new firms and both US and international corporate entrepreneurial ventures to navigate the industry landscape and bring new solutions to market efficiently.
RxMarketSCIENCE makes decoding the prescription drug industry developments and earnings calls easier and more meaningful for investment experts. We provide industry briefing and expert opinions for Investment firm's client base and help them understand investment target's prospects and risks better.